« Back to Record
Tsourdi, E., Zillikens, M. C. C. M., Meier, C., Body, J.-J., Gonzalez Rodriguez, E., Anastasilakis, A. A., Abrahamsen, B., Mccloskey, E., Hofbauer, L. C., Guañabens, N., Obermayer-Pietsch, B., Ralston, S., Eastell, R., Pepe, J., Palermo, A., & Langdahl, B. (2021). Fracture Risk and Management of Discontinuation of Denosumab Therapy: A Systematic Review and Position Statement by ECTS. The Journal of clinical endocrinology and metabolism, 106(1), 264-281. doi:10.1210/clinem/dgaa756
Citation APA
Permalink
Permalink
http://hdl.handle.net/2013/ULB-DIPOT:oai:dipot.ulb.ac.be:2013/320461



